Using the AirSeal System for Robot-assisted Prostate Surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of the AirSeal system in providing low-pressure pneumoperitoneum during robot-assisted radical prostatectomy for patients with prostate cancer. The study compares outcomes between patients using the AirSeal system and those using conventional insufflation methods. It aims to gather data on operative times, hospital stays, and complication rates associated with the AirSeal system. The research seeks to establish the cost-benefit and overall effectiveness of this innovative surgical approach.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with prostate cancer who will undergo robotic prostatectomy;

Exclusion Criteria:

* Patients over 65 and under 18 years of age;
* Patients allergic to NSAIDs and/or Morphine and/or Tramadol;
* Patients with chronic renal failure;
* Patients with recurrence, metastasis and other existing neoplasms.

Where it's running

• Instituto Brasileiro de Cirurgia Robotica
  Salvador, Estado de Bahia, Brazil Recruiting
• Hospital Mater Dei Salvador
  Salvador, Estado de Bahia, Brazil Recruiting

Study contacts

• Principal investigator: Nilo J. Md — Brazilian Institute of Robotic Surgery
• Study coordinator: Nilo Jorge Leão Coordenador
• Email: ibcrpesquisa@gmail.com
• Phone: +55 71 2626-3030

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Fezolinetant to reduce hot flashes in men on androgen-deprivation therapy

  This trial will test whether taking fezolinetant once daily for 4 weeks reduces how often and how severe hot flashes are in men with prostate cancer who are on androgen-deprivation therapy.

  Recruiting Phase 2 Brigham and Women's Hospital · Boston, Massachusetts · NCT06957691

• Understanding NK Cell Function in Prostate Cancer Across Races

  This study tests whether natural killer (NK) cells behave differently in prostate cancer patients of diverse racial backgrounds by analyzing blood and tissue samples.

  Recruiting Masonic Cancer Center, University of Minnesota · Minneapolis, Minnesota · NCT07910019

• MRI or CT planning to guide high-dose-rate prostate brachytherapy

  This trial tests whether adding an MRI to CT-based treatment planning for HDR prostate brachytherapy changes urinary side effects in men with localized prostate cancer.

  Recruiting at 3 sites Emory University · Atlanta, Georgia and 2 other locations · NCT07859722

• Active surveillance after immunotherapy for MMR-deficient colorectal and GI cancers

  This study looks at whether some patients with non-metastatic, MMR-deficient or MSI-H colorectal cancers can skip surgery after a strong response to immunotherapy.

  Recruiting at 3 sites University Hospital, Basel, Switzerland · Basel and 2 other locations · NCT07829081

• Ultrahypofractionated Proton Therapy for Localized Prostate Cancer

  This study tests whether a short course of proton beam therapy can control localized prostate cancer with acceptable safety.

  Recruiting National Cancer Center, Korea · Goyang-si, Gyeonggi-do · NCT07699705

• Effect of Resistance Training on Muscle Mass and Mental Health in Adults on Obesity Medication

  This study tests whether 60 minutes of resistance training twice a week for 3 months helps people on GLP-1 RAs keep muscle and feel mentally better.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07652333

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.